Özen, Y. Et Al. 2024. Empagliflozin and Dapagliflozin Therapies Favorably Alter QRS-T Angle and Cardiac Repolarization Parameters in Patients with Heart Failure. Journal of Innovations in Cardiac Rhythm Management , vol.15, no.4 , 5846-5851.

Özen, Y., Özbay, M. B., Nriagu, B. N., Yakut, İ., KANAL, Y., Çetin, E. H. Ö., ... Oktay, A. A.(2024). Empagliflozin and Dapagliflozin Therapies Favorably Alter QRS-T Angle and Cardiac Repolarization Parameters in Patients with Heart Failure. Journal of Innovations in Cardiac Rhythm Management , vol.15, no.4, 5846-5851.

Özen, Yasin Et Al. "Empagliflozin and Dapagliflozin Therapies Favorably Alter QRS-T Angle and Cardiac Repolarization Parameters in Patients with Heart Failure," Journal of Innovations in Cardiac Rhythm Management , vol.15, no.4, 5846-5851, 2024

Özen, Yasin Et Al. "Empagliflozin and Dapagliflozin Therapies Favorably Alter QRS-T Angle and Cardiac Repolarization Parameters in Patients with Heart Failure." Journal of Innovations in Cardiac Rhythm Management , vol.15, no.4, pp.5846-5851, 2024

Özen, Y. Et Al. (2024) . "Empagliflozin and Dapagliflozin Therapies Favorably Alter QRS-T Angle and Cardiac Repolarization Parameters in Patients with Heart Failure." Journal of Innovations in Cardiac Rhythm Management , vol.15, no.4, pp.5846-5851.

@article{article, author={Yasin Özen Et Al. }, title={Empagliflozin and Dapagliflozin Therapies Favorably Alter QRS-T Angle and Cardiac Repolarization Parameters in Patients with Heart Failure}, journal={Journal of Innovations in Cardiac Rhythm Management}, year=2024, pages={5846-5851} }